Radiation therapy can lower the chance of cancer recurrence in patients with low-risk breast cancer following breast conservation surgery, according to data presented Oct. 21 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

STAMFORD, Conn.—FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, today introduced the FCT Embrace. Powered by Analogic, the FCT Embrace is the world’s first 85cm wide bore computed tomography (CT) imaging unitwith 64 or 128 slice configurations. Optimized for both oncology and radiology applications, the FCT Embrace, combined with other market-leading oncology solutions, offers enhanced and efficient CT Simulation with radiotherapy treatment planning capabilities. The unveiling at booth #3063 during the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting marks Fujifilm’s entry into the CT market, expanding its end-to-end diagnostic imaging product portfolio which is recognized for exceptional imaging at low dose.

TUSTIN, Calif.—At this year’s American Society of Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas, October 21-24, 2018 (Booth #3737), Canon Medical Systems USA, Inc. will showcase its recently FDA-cleared Aquilion PrecisionTM, the world’s first Ultra-High Resolution CT system. The system can resolve anatomy as small as 150 microns and is designed to provide more than twice the CT resolution as standard systems. Containing an all-new detector as well as tube, gantry and reconstruction technologies, the system may make it possible to help expand visualization of disease thanks to new features that offer improved image detail.

Research published in the Journal of the American Medical Association: Oncology debunked the widely accepted rule that cancer patients should not use topical skin treatments before radiation treatments.

Hospitals across the United States spent approximately $25.4 billion more than necessary this year on supply chain operations, according to a new report from Chicago-based Navigant Consulting. That number is up more than 10 percent compared to 2017.

Breast density notification laws were designed to motivate supplemental breast cancer screening among women at an increased risk. However, they have resulted in more low-risk women undergoing unnecessary supplemental screening, according to new research published in the Journal of the American College of Radiology.

Novartis, a large healthcare company based in Basel, Switzerland, has agreed to acquire Endocyte, a West Lafayette, Indiana-based biopharmaceutical company, for $2.1 billion.

The Orlando-based Florida Hospital health system is launching a new initiative focused on lessening the impact of chemotherapy’s various adverse side effects on the hearts of breast cancer patients.

Researcher J. Quincy Brown, an associate professor of biomedical engineering at Tulane University in New Orleans, has been awarded a $1.6 million grant to develop a rapid microscopy scanner that could ensure cancer patients' tumors are completely removed during surgery.

Machine learning (ML) has become one of the hottest topics in radiology and all of healthcare, but reading the latest and greatest ML research can be difficult, even for experienced medical professionals. A new analysis published in the American Journal of Roentgenology was written with that very problem in mind.